CLINICAL_TRIALS
trial_result
· 2014-10-06
Clinical Trial Update: ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial [Phase 2]
Summary
A Phase 2 trial of ZACtima/FASlodex for postmenopausal advanced breast cancer was terminated, with results posted on 2014-10-06.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-10-06